{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T14:22:04Z","timestamp":1791037324371,"version":"4.1.0"},"reference-count":49,"publisher":"Wiley","issue":"5","license":[{"start":{"date-parts":[[2009,1,9]],"date-time":"2009-01-09T00:00:00Z","timestamp":1231459200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["European J of Haematology"],"published-print":{"date-parts":[[2009,5]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>The clinical phenotype of myelofibrosis (MF) is recognized either <jats:italic>de novo<\/jats:italic> (primary) or in the setting of polycythemia vera (post\u2010PV) or essential thrombocythemia (post\u2010ET). Approximately one\u2010third of patients with primary MF (PMF) present with cytogenetic abnormalities; the most frequent are del(20q), del(13q), trisomy 8 and 9, and abnormalities of chromosome 1 including duplication 1q. Other less frequent lesions include \u22127\/del(7q), del(5q), del(12p), +21 and der(6)t(1;6)(q21;p21.3). In general, cytogenetic abnormalities are qualitatively similar among PMF, post\u2010ET MF and post\u2010PV MF although their individual frequencies may differ. Based on prognostic effect, cytogenetic findings in MF are classified as either \u2018favorable\u2019 or \u2018unfavorable\u2019. The former include normal karyotype or isolated del(20q) or del(13q) and the latter all other abnormalities. Unfavorable cytogenetic profile in both PMF and post\u2010PV\/ET MF confers an independent adverse effect on survival; it is also associated with higher <jats:italic>JAK2<\/jats:italic>V617F mutational frequency. In addition to their prognostic value, cytogenetic studies in MF ensure diagnostic exclusion of other myeloid neoplasms that are sometimes associated with bone marrow fibrosis (e.g. <jats:italic>BCR\u2010ABL1<\/jats:italic>\u2010positive or <jats:italic>PDGFRB<\/jats:italic>\u2010rearranged) and also assist in specific treatment selection (e.g. lenalidomide therapy is active in MF associated with del(5q).<\/jats:p>","DOI":"10.1111\/j.1600-0609.2009.01224.x","type":"journal-article","created":{"date-parts":[[2009,1,9]],"date-time":"2009-01-09T05:09:13Z","timestamp":1231477753000},"page":"329-338","source":"Crossref","is-referenced-by-count":82,"title":["Conventional cytogenetics in myelofibrosis: literature review and discussion"],"prefix":"10.1111","volume":"82","author":[{"given":"Kebede","family":"Hussein","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel L.","family":"Van Dyke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ayalew","family":"Tefferi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2009,4,6]]},"reference":[{"key":"e_1_2_4_2_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.leu.2404955"},{"key":"e_1_2_4_3_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0609.2008.01038.x"},{"key":"e_1_2_4_4_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2008-07-170449"},{"key":"e_1_2_4_5_2","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.21183"},{"key":"e_1_2_4_6_2","first-page":"18","volume-title":"WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues","author":"Vardiman JW","year":"2008"},{"key":"e_1_2_4_7_2","doi-asserted-by":"publisher","DOI":"10.1038\/leu.2008.113"},{"key":"e_1_2_4_8_2","doi-asserted-by":"publisher","DOI":"10.1038\/leu.2008.218"},{"key":"e_1_2_4_9_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0609.2009.01216.x"},{"key":"e_1_2_4_10_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2141.2001.02796.x"},{"key":"e_1_2_4_11_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2141.1997.1722990.x"},{"key":"e_1_2_4_12_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V88.3.1013.1013"},{"key":"e_1_2_4_13_2","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.21358"},{"key":"e_1_2_4_14_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.1994.tb05076.x"},{"key":"e_1_2_4_15_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.cancergencyto.2006.09.021"},{"key":"e_1_2_4_16_2","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1182\/blood.V72.3.855.bloodjournal723855","article-title":"Cytogenetic studies and their prognostic significance in agnogenic myeloid metaplasia: a report on 47 cases","volume":"72","author":"Demory JL","year":"1988","journal-title":"Blood"},{"key":"e_1_2_4_17_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0165-4608(02)00678-7"},{"key":"e_1_2_4_18_2","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(19850201)55:3<582::AID-CNCR2820550318>3.0.CO;2-O"},{"key":"e_1_2_4_19_2","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.22318"},{"key":"e_1_2_4_20_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2004-11-4319"},{"key":"e_1_2_4_21_2","doi-asserted-by":"publisher","DOI":"10.1016\/0165-4608(87)90092-6"},{"key":"e_1_2_4_22_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.leu.2404914"},{"key":"e_1_2_4_23_2","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.21868"},{"key":"e_1_2_4_24_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0609.2007.01003.x"},{"key":"e_1_2_4_25_2","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1182\/blood.V72.2.386.386","article-title":"A prospective long\u2010term cytogenetic study in polycythemia vera in relation to treatment and clinical course","volume":"72","author":"Swolin B","year":"1988","journal-title":"Blood"},{"key":"e_1_2_4_26_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0609.1976.tb01174.x"},{"key":"e_1_2_4_27_2","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.2830220206"},{"key":"e_1_2_4_28_2","first-page":"3626","article-title":"Cytogenetic abnormalities in essential thrombocythemia: prevalence and prognostic significance","volume":"108","author":"Wolanskyj AP","year":"2006","journal-title":"ASH Annual Meeting Abstracts"},{"key":"e_1_2_4_29_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.2005.05593.x"},{"key":"e_1_2_4_30_2","doi-asserted-by":"publisher","DOI":"10.1159\/000064754"},{"key":"e_1_2_4_31_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2004-07-2864"},{"key":"e_1_2_4_32_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00277-008-0461-4"},{"key":"e_1_2_4_33_2","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.21297"},{"key":"e_1_2_4_34_2","doi-asserted-by":"publisher","DOI":"10.1016\/0165-4608(89)90127-1"},{"key":"e_1_2_4_35_2","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1182\/blood.V91.1.231","article-title":"Molecular delineation of 13q deletion boundaries in 20 patients with myeloid malignancies","volume":"91","author":"La Starza R","year":"1998","journal-title":"Blood"},{"key":"e_1_2_4_36_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.onc.1203728"},{"key":"e_1_2_4_37_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00277-008-0462-3"},{"key":"e_1_2_4_38_2","first-page":"2055","article-title":"Unbalanced chromosome rearrangements involving the 20q11.2 region in myeloid malignancy","volume":"112","author":"Howard\u2010Reeves J","year":"2008","journal-title":"ASH Annual Meeting Abstracts"},{"key":"e_1_2_4_39_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.leukres.2008.04.022"},{"key":"e_1_2_4_40_2","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.21245"},{"key":"e_1_2_4_41_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.leukres.2007.07.007"},{"key":"e_1_2_4_42_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.leu.2404852"},{"key":"e_1_2_4_43_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0610477104"},{"key":"e_1_2_4_44_2","doi-asserted-by":"publisher","DOI":"10.1038\/nature06494"},{"key":"e_1_2_4_45_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.leu.2404711"},{"key":"e_1_2_4_46_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa061292"},{"key":"e_1_2_4_47_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2008-04-152678"},{"key":"e_1_2_4_48_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2008-10-182170"},{"key":"e_1_2_4_49_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2141.2002.03763.x"},{"key":"e_1_2_4_50_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2007-03-082404"}],"container-title":["European Journal of Haematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1600-0609.2009.01224.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1600-0609.2009.01224.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,10]],"date-time":"2023-10-10T19:17:54Z","timestamp":1696965474000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1600-0609.2009.01224.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,4,6]]},"references-count":49,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2009,5]]}},"alternative-id":["10.1111\/j.1600-0609.2009.01224.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1600-0609.2009.01224.x","archive":["Portico"],"relation":{},"ISSN":["0902-4441","1600-0609"],"issn-type":[{"value":"0902-4441","type":"print"},{"value":"1600-0609","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,4,6]]}}}